| NCT ID | NCT02986048 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Case Comprehensive Cancer Center |
| Condition | Treatment With Proton Beam Radiation Therapy |
| Study Type | OBSERVATIONAL |
| Enrollment | 999 participants |
| Start Date | 2016-11-22 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 999 participants in total. It began in 2016-11-22 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to establish a database (or "registry") of patients treated with proton beam therapy at the University Hospitals (UH) Proton Therapy Center. By keeping track of the patients treated it will allow the investigators to periodically evaluate the outcomes of patients.
Eligibility Criteria
Inclusion Criteria: * Patients treated with proton beam at the UH Proton Therapy Center * Patients who have the ability to understand and be willing to sign a written informed consent document Exclusion Criteria: * Patients or legal guardians who are unable to understand informed consent document
Contact & Investigator
David B Mansur, MD
PRINCIPAL INVESTIGATOR
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Frequently Asked Questions
Who can join the NCT02986048 clinical trial?
This trial is open to participants of all sexes, studying Treatment With Proton Beam Radiation Therapy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02986048 currently recruiting?
Yes, NCT02986048 is actively recruiting participants. Contact the research team at CTUReferral@UHhospitals.org for enrollment information.
Where is the NCT02986048 trial being conducted?
This trial is being conducted at Cleveland, United States.
Who is sponsoring the NCT02986048 clinical trial?
NCT02986048 is sponsored by Case Comprehensive Cancer Center. The principal investigator is David B Mansur, MD at University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center. The trial plans to enroll 999 participants.